Results from the Phase I/II trials for ChAdOx1 nCoV-19, the vaccine developed by scientists at The University of Oxford’s Jenner Institute and the Oxford Vaccine group, have been published today in scientific journal, The Lancet.
Results from the Phase I/II trials for ChAdOx1 nCoV-19, the vaccine developed by scientists at The University of Oxford’s Jenner Institute and the Oxford Vaccine group, have been published today in scientific journal, The Lancet.